Search clinical trials for: Duloxetine hydrochloride

Total 7561 results

Janssen Research & Development, LLC

Completed

An Observational Study of Men With Premature Ejaculation Who Are Treated With Dapoxetine Hydrochloride or Alternate Care Defined as Any Treatment Other Than Dapoxetine Hydrochloride

Sexual Dysfunction, Physiological | Ejaculation

Germany, Spain, Portugal, Finland, Sweden, Austria
Janssen Research & Development, LLC
Cegedim Strategic Data

Completed

PRILIGY Usage Patterns in Selected Populations

Sexual Dysfunction, Physiological
Xidian University

Unknown

Investigation of the Changes of Brain Structure and Function in Premature Ejaculation Patients and the Effects of Dapoxetine on Central Neural Activity in Premature Ejaculation Patients

Premature Ejaculation

China
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Completed

Study of Desvenlafaxine in Treating Major Depressive Disorder.

Major Depressive Disorder

China
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Recruiting

Study of Ammoxetine Hydrochloride Enteric-coated Tablets in Subjects With Depression

Major Depressive Disorder (MDD)

China
Shanghai Mental Health Center
Jiangsu Nhwa Pharmaceutical Co., Ltd.

Completed

A Study to Evaluate the Pharmacokinetics of Duloxetine in Chinese Han Healthy Subjects

Healthy

China
d_yarnitsky

Completed

Multiparametric MRI Study of Endogenous Analgesia and Prediction the Efficacy of Migraine Pharmacological Prevention

Migraine

Israel
Eli Lilly and Company
Shionogi

Completed

A Study for the Treatment of Diabetic Peripheral Neuropathic Pain

Diabetic Neuropathies

Japan
prof. Peter de Jonge

Unknown

Initial Severity and Antidepressant Efficacy for Anxiety Disorders: an Individual Patient Data Meta-analysis

Anxiety Disorders | Generalized Anxiety Disorder | Social Anxiety Disorder | Panic Disorder | Post-traumatic Stress Disorder | Obsessive-compulsive Disorder
Boehringer Ingelheim

Completed

Duloxetine in Patients With Diabetic in Peripheral Neuropathic Pain With or Without Co-morbid Major Depressive Disorder

Diabetic Neuropathies | Depressive Disorder, Major

Germany
Tasly Pharmaceutical Group Co., Ltd

Recruiting

A Study of the Effectiveness and Safety of JS1-1-01 in Patients With Moderate to Severe Depression

Depression

China
Eli Lilly and Company

Completed

A Study in the Treatment of Children and Adolescents With Major Depressive Disorder

Major Depressive Disorder

United States, Germany, Russian Federation, South Africa, France, Ukraine, Slovakia
Eli Lilly and Company

Completed

A Study in the Treatment of Children and Adolescents With Major Depressive Disorder

Major Depressive Disorder

Mexico, United States, Argentina, Canada
Eli Lilly and Company

Completed

A Comparison of Tolerability and Efficacy of Different Doses of Duloxetine for the Treatment of Major Depressive Disorder

Depressive Disorder

United States
Eli Lilly and Company

Completed

Tolerability of Switching to Duloxetine for the Management of Diabetic Nerve Pain

Diabetic Neuropathy, Painful

United States, Puerto Rico
Eli Lilly and Company

Completed

Lilly's Emotional and Physical Symptoms of Depression Study (LEAPS) (LEAPS)

Major Depressive Disorder

United States
University of Pittsburgh
Eli Lilly and Company; National Institutes of Health (NIH)

Completed

Duloxetine Treatment of Major Depression and Chronic Low Back Pain For Older Adults (ACHIEVE2)

Back Pain | Major Depressive Disorder | Aged

United States
Hamilton Health Sciences Corporation
St. Joseph's Healthcare Hamilton; Eli Lilly and Company; McMaster University

Unknown

Duloxetine for Major Depression in Peri-/Postmenopausal Women

Major Depressive Disorder

Canada
New York State Psychiatric Institute
Eli Lilly and Company

Completed

Duloxetine for Chronic Depression: a Double-blind Study

Dysthymic Disorder | Depressive Disorder NOS

United States
Canive, Jose M., M.D.
Eli Lilly and Company

Unknown

Open-Label Duloxetine Monotherapy in the Treatment of Posttraumatic Stress Disorder

Posttraumatic Stress Disorders

United States
Eli Lilly and Company

Completed

A Study for the Treatment of Painful Diabetic Neuropathy

Diabetic Neuropathy, Painful

United States
Eli Lilly and Company
Boehringer Ingelheim

Completed

To Determine How Effective Duloxetine is in Treating Women 65 Years and Older With Symptoms of Stress Urinary Incontinence, or With a Combination of Stress Urinary Incontinence and Urge Urinary Incontinence Symptoms

Urinary Incontinence, Stress

France, Sweden, Netherlands, Spain, Germany, South Africa, Switzerland
Eli Lilly and Company
Shionogi

Completed

A Long-term Study for the Treatment of Painful Diabetic Neuropathy

Diabetic Neuropathies

Japan
Eli Lilly and Company
Boehringer Ingelheim

Completed

Duloxetine Compared With Placebo in Patients With Generalized Anxiety Disorder

Anxiety Disorders

United States, Finland, France, Germany, South Africa, Spain, Sweden
Chen Qian

Recruiting

Clinical Study of Cang Ai Volatile Oil (CAVO) on Mild to Moderate Depression in Children and Adolescents

Depression

China
Eli Lilly and Company
Boehringer Ingelheim

Completed

A Study Evaluating Duloxetine in Patients Hospitalized for Severe Depression

Major Depressive Disorder

France, Italy, Russian Federation, South Africa
Eli Lilly and Company
Boehringer Ingelheim

Completed

A Duloxetine Dosing Strategy Study in Korean Patients With Major Depressive Disorder

Major Depressive Disorder (MDD)

Korea, Republic of
Eli Lilly and Company

Completed

Study on the Tolerability of Duloxetine in Depressed Patients With Parkinson's Disease

Major Depressive Disorder | Idiopathic Parkinson Disease

Italy
Wake Forest University Health Sciences

Not yet recruiting

Identifying and Treating Depression in the Orthopaedic Trauma Population

Depression

United States
Eli Lilly and Company
Boehringer Ingelheim

Completed

A Study Comparing Duloxetine to Other Antidepressants in the Treatment of Severe Depression (TRY FIRST)

Depression

United States
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Completed

Duloxetine in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer

Pain | Unspecified Adult Solid Tumor, Protocol Specific | Neurotoxicity | Peripheral Neuropathy

United States
Eli Lilly and Company
Boehringer Ingelheim

Completed

A Study Comparing the Efficacy and Safety of Duloxetine and Placebo for the Treatment of Depression in Elderly Patients

Major Depressive Disorder

United States, France, Mexico, Puerto Rico
Eli Lilly and Company
Boehringer Ingelheim

Completed

A Study Comparing Duloxetine and Placebo in the Treatment of Fibromyalgia

Fibromyalgia

United States, Puerto Rico
University Medical Center Groningen

Unknown

Early Improvement in Individual Symptoms and Response to Antidepressants in Patients With Major Depressive Disorder

Major Depressive Disorder
Boehringer Ingelheim

Completed

Tolerability and Safety of Duloxetine BID in Healthy Female Subjects

Healthy
Eli Lilly and Company

Completed

A Study Comparing Duloxetine and Placebo in Assessing Energy and Vitality in Major Depressive Disorder (MDD) Patients

Major Depressive Disorder

United States, Puerto Rico
Southwest Oncology Group
National Cancer Institute (NCI)

Completed

S1202: Duloxetine Hydrochloride for Muscle/Joint Pain in Early-Stage Breast Cancer Receiving Hormone Therapy

Pain | Breast Cancer | Musculoskeletal Complications

United States
Eli Lilly and Company

Completed

Duloxetine for Multiple Sclerosis Pain

Multiple Sclerosis

United States, Canada, Belgium, Poland
University of Nottingham
Arthritis Research UK

Completed

Imaging Pain Relief in Osteoarthritis (IPRO)

Osteoarthritis | Chronic Pain

United Kingdom
Ilker Fatih Sari

Completed

The Effect of Transcutaneous Posterior Tibial Nerve Stimulation in Patients With Fibromyalgia

Fibromyalgia

Turkey
Rhode Island Hospital
National Institute of General Medical Sciences (NIGMS); Mayday Fund

Completed

Altering The Transition From Acute to Chronic Pain (ATTAC-Pain) (ATTAC-PAIN)

Musculoskeletal Pain

United States
Institute of Liver and Biliary Sciences, India

Completed

A Trial to Study the Influence of Growth Factors on Bone Marrow and Hepatic Regeneration in Patients With Decompensated Cirrhosis.

Decompensated Cirrhosis

India
Pfizer

Withdrawn

A Study of Duloxetine Hydrochloride Hard Gelatinous Capsule Compared To Cymbalta

Healthy
Pfizer

Withdrawn

A Study Of Duloxetine Hydrochloride Hard Gelatinous Capsule Compared To Cymbalta Under Fed Conditions

Healthy
National Taiwan University Hospital

Terminated

Effects of Duloxetine on Pathological Worry in Patients With Generalized Anxiety Disorder: A fMRI Study

Anxiety | Worry

Taiwan
Eli Lilly and Company
Boehringer Ingelheim

Completed

A Comparison of Duloxetine Hydrochloride, Marketed Comparator, and Placebo in the Treatment of Generalized Anxiety Disorder

Anxiety Disorder

Argentina, Australia, Belgium, Canada, Mexico, Russian Federation, Taiwan, United Kingdom
Eli Lilly and Company
Boehringer Ingelheim

Completed

A Comparison of Duloxetine Hydrochloride, Marketed Comparator, and Placebo in the Treatment of Generalized Anxiety Disorder

Anxiety Disorders

United States
Centre Hospitalier Universitaire Vaudois
Hospices Civils de Lyon; University Hospital, Geneva; Central Hospital, Nancy...

Unknown

Antidepressants During Pregnancy and Lactation: Pharmacokinetics and Clinical Implications

Depressive Disorder | Lactation

France, Switzerland
Teva Pharmaceuticals USA

Completed

90 mg Fluoxetine Hydrochloride Capsules Under Fasting Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

90 mg Fluoxetine Hydrochloride Capsules Under Non-Fasting Conditions

Healthy

United States

Search clinical trials for: Duloxetine hydrochloride

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in New Zealand

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations